Friend or Foe: Paradoxical Roles of Autophagy in Gliomagenesis

被引:20
|
作者
Batara, Don Carlo Ramos [1 ]
Choi, Moon-Chang [2 ]
Shin, Hyeon-Uk [1 ]
Kim, Hyunggee [3 ]
Kim, Sung-Hak [1 ]
机构
[1] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Anim Sci, Gwangju 61186, South Korea
[2] Chosun Univ, Dept Biomed Sci, Gwangju 61452, South Korea
[3] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 02841, South Korea
基金
新加坡国家研究基金会;
关键词
glioblastoma multiforme; autophagy; treatment; NEWLY-DIAGNOSED GLIOBLASTOMA; HYPOXIA-INDUCED AUTOPHAGY; PHASE-II TRIAL; POTENTIATES TEMOZOLOMIDE CYTOTOXICITY; SUBEROYLANILIDE HYDROXAMIC ACID; PROMOTES CELL-PROLIFERATION; GLIOMA-CELLS; SIGNALING PATHWAY; IN-VITRO; VASCULOGENIC MIMICRY;
D O I
10.3390/cells10061411
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor in adults, with a poor median survival of approximately 15 months after diagnosis. Despite several decades of intensive research on its cancer biology, treatment for GBM remains a challenge. Autophagy, a fundamental homeostatic mechanism, is responsible for degrading and recycling damaged or defective cellular components. It plays a paradoxical role in GBM by either promoting or suppressing tumor growth depending on the cellular context. A thorough understanding of autophagy's pleiotropic roles is needed to develop potential therapeutic strategies for GBM. In this paper, we discussed molecular mechanisms and biphasic functions of autophagy in gliomagenesis. We also provided a summary of treatments for GBM, emphasizing the importance of autophagy as a promising molecular target for treating GBM.
引用
收藏
页数:28
相关论文
共 50 条
  • [31] Is the autophagy a friend or foe in the silver nanoparticles associated radiotherapy for glioma ?
    Wu, Hao
    Lin, Jun
    Liu, Peidang
    Huang, Zhihai
    Zhao, Peng
    Jin, Haizhen
    Wang, Cailian
    Wen, Longping
    Gu, Ning
    BIOMATERIALS, 2015, 62 : 47 - 57
  • [32] Is Autophagy a Friend or Foe in SARS-CoV-2 Infection?
    Khan, Asifa
    Ling, Jiaxin
    Li, Jinlin
    VIRUSES-BASEL, 2024, 16 (09):
  • [33] Autophagy: Friend or Foe in Breast Cancer Development, Progression, and Treatment
    Berardi, Damian E.
    Campodonico, Paola B.
    Diaz Bessone, Maria Ines
    Urtreger, Alejandro J.
    Todaro, Laura B.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2011, 2011
  • [34] Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night
    Mathew, Robin
    White, Eileen
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) : 113 - 119
  • [35] Dual inhibition of mTOR in hepatocellular carcinoma: Autophagy friend or foe?
    Pereira Da Veiga, Sonia
    Mercer, Carol
    Ge Xuemei
    Thomas, Hala Elnakat
    Kozma, Sara
    Thomas, George
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [36] Friend or Foe? Essential Roles of Osteoclast in Maintaining Skeletal Health
    Wang, Haixing
    Yang, Guangpu
    Xiao, Yinbo
    Luo, Guotian
    Li, Gang
    Li, Ziqing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [37] FOLATE: FRIEND OR FOE? AN INVESTIGATION INTO THE OPPOSING ROLES OF FOLATE IN GLIOMA
    Rudd, Michelle Claire
    Lea, Robert
    Alder, Jane
    NEURO-ONCOLOGY, 2018, 20 : 17 - 17
  • [38] The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
    Glorieux, Christophe
    Enriquez, Cinthya
    Gonzalez, Constanza
    Aguirre-Martinez, Gabriela
    Calderon, Pedro Buc
    ANTIOXIDANTS, 2024, 13 (01)
  • [39] Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer
    Song, Jingjing
    Wu, Lihui
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [40] Autophagy in sepsis-induced acute lung injury: Friend or foe?
    Zhao, Jiayao
    Liang, Qun
    Fu, Chenfei
    Cong, Didi
    Wang, Long
    Xu, Xiaoxin
    CELLULAR SIGNALLING, 2023, 111